Weight Loss

Sports & Active Nutrition Summit 2024

How GLP-1 users are shaking up the dietary supplement industry

By Danielle Masterson

At the recent Sports and Active Nutrition Summit, GLP-1 medications was a hot topic – with just about every panel receiving a question about the medication’s impact on the sector. While weight loss medications can present challenges for the industry,...

The skinny on berberine: Is it really #naturesozempic?

The skinny on berberine: Is it really #naturesozempic?

By Asia Sherman

Botanical extract berberine rose to viral fame earlier this year, touted by TikTok influencers as a weight loss miracle molecule and given the hashtag #naturesozempic. Social media, however, may not always be a credible source of information.

Getty | Rotislav Sedlacek

Pomegranate extract study reveals promise in weight loss category

By Nicola Gordon-Seymour

Consumption of pomegranate leaf extract (PLE) and pomegranate juice (PJ) can increase satiety, satisfaction, and fullness, and reduce the desire to eat, indicating their potential in weight loss therapy, according to a trial conducted by researchers at...

Getty Images / globalmoments

Paper highlights safety of some weight management ingredients

By Danielle Masterson

With weight loss supplements under attack in several states, researchers rebut with science. The authors of a new paper examine the safety of six ingredients, a move they hope will encourage since-based decisions.

NutraIngredients-USA photo

No dieting silver bullets, expert says

By Hank Schultz

Sports nutrition products are often linked to certain diet plans, such as ketogenic diets, high protein/low fat approaches and others. A nutrition expert says the prosaic takeaway is that all of these have been shown to work, provided that consumers...

iStock / Marques Photography

Mouse study backs weight loss potential of curcumin, piperine combo

By Adi Menayang

Mice given curcumin and piperine while on a calorie restricted diet lost more fat than control group mice and exhibited significantly lower plasma inflammatory markers associated with obesity, according to researchers from Tufts University in Boston and...

SATIN chief: “...even if not combined with another effective mono-therapy it could become a very powerful tool.”

"We hope to develop a pill for fexaramine within 24 to 36 months to try in humans."

Satiety pill shows metabolic syndrome potential: Mice study

By Shane STARLING

The mainstream press has latched onto a mouse study that shows a bile-controlling, gut restricted pharma intervention can mimic food intake and therefore potentially be an obesity beater. But could it pass clinical inspection? One weight loss researcher...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All